Open AccessMedicineBiology

R. Jope, Christopher J. Yuskaitis, Eléonore Beurel

2007.3.22NEUROCHEMICAL RESEARCH

DOI: 10.1007/s11064-006-9128-5

tlooto Summary

GSK3 may contribute not only to primary pathologies in these diseases, but also to the associated inflammation, suggesting that GSK3 inhibitors may have multiple effects influencing these conditions.

Abstract

Abstract is not available.

Citation format

JOPE, R.; YUSKAITIS, Christopher J.; BEUREL, Eléonore. Glycogen synthase kinase-3 (GSK3): Inflammation, diseases, and therapeutics. NEUROCHEMICAL RESEARCH, 2007, 32: 577–595.